Suchergebnisse - %22Viral infection%22

PubPharm (23)

1

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

enthalten in: Cell | 2024

von Zhang, L. | Kempf, A. | Nehlmeier, I. | +15

2

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by Betacoronavirus

enthalten in: Viruses | 2023

von Pereira, R. | Rabelo, R. | Oliveira, N. | +15

3

Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients

enthalten in: International journal of biological sciences | 2023

von Beltrán-Camacho, L. | Bhosale, S. | Sánchez-Morillo, D. | +12

4

Perspective : Role of Micronutrients and Omega-3 Long-Chain Polyunsaturated Fatty Acids for Immune Outcomes of Relevance to Infections in Older Adults-A Narrative Review and Call for Action

enthalten in: Advances in nutrition (Bethesda, Md.) | 2022

von Eggersdorfer, M. | Berger, M. | Calder, P. | +4

5

Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease

enthalten in: Biochemical and biophysical research communications | 2022

von Wei, W. | Kong, N. | Liu, M. | +3

6

When cyclin-dependent kinases meet viral infections, including SARS-CoV-2

enthalten in: Journal of medical virology | 2022

von Yan, Y. | Tang, Y. | Zheng, C.

7

The OVID study will show whether prophylactic-dose enoxaparin improves survival and reduces any hospitalizations in ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation : ENOXAPARIN FOR PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY PATIENTS WITH CORONAVIRUS: THE MULTICENTER RANDOMIZED CONTROLLED OVID TRIAL

enthalten in: WHO International Clinical Trials Registry Platform | 2022

8

The OVID study will show whether prophylactic-dose enoxaparin improves survival and reduces any hospitalizations in ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation : ENOXAPARIN FOR PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY PATIENTS WITH CORONAVIRUS: THE MULTICENTER RANDOMIZED CONTROLLED OVID TRIAL

enthalten in: WHO International Clinical Trials Registry Platform | 2022

9

Potential Role of Selenium in the Treatment of Cancer and Viral Infections

enthalten in: International journal of molecular sciences | 2022

von Rataan, A. | Geary, S. | Zakharia, Y. | +2

10

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

enthalten in: Nature cancer | 17 June 2022

von Walle, T. | Bajaj, S. | Kraske, J. | +32